Pre-FDA • Technology under development

KiiS — Exploring the Next Evolution of Dental Implants

KiiS — 치과 임플란트의 다음 진화를 탐구합니다

Researching a transition from surface fixation to 3-D bone integration — without changing established workflows.

KiiS = Kim’s Ingrowth Implant System (current R&D); also used for Kim’s Injectable Implant System in our drug-delivery roadmap.

  • Patented internal chamber designed to enable research into 3-D load sharing
  • Compatible with standard conical connection and instruments
  • FDA 510(k) preparation is ongoing; remaining tasks include fatigue verification, final surface characterization, and documentation

Why KiiS

Internal bone-ingrowth chamber

Concept intended to support research into multi-directional fixation beyond surface contact.

Seamless workflow

Standard conical connection designed for familiar clinical protocols.

Injectable platform roadmap

Conceptual roadmap for potential drug-delivery applications in peri-implant care research.

3-D Integration, Visualized

Micro-CT observations in preclinical models show bone ingrowth into the internal chamber, supporting multi-directional fixation research.

Micro-CT image showing bone ingrowth into internal chamber of KiiS
Micro-CT (10μ) in canine mandibular bone — 6 weeks post-implantation.

Potential Clinical Contexts

Everyday cases (primary implants)
  • Compatible with universal prosthetic workflows
  • 11° conical seal to support soft-tissue management
  • Chamber concept aims to inform research on early & long-term stability
Complex cases (soft/fragile bone & compromised sites)
  • Progressive thread design for controlled torque in soft bone
  • Chamber supports staged regeneration & sustained load-sharing research
  • Open drilling sequence — no exclusive kits required

Intellectual Property

  • U.S. Patent No. 9,757,213 B2 — Hybrid Dental Implant (issued Sept. 12, 2017)
  • PCT filing to support international patent strategy under the Patent Cooperation Treaty